Bosacki Claire, Vallard Alexis, Gras Mathilde, Daguenet Elisabeth, Morisson Stéphanie, Méry Benoite, Jmour Omar, Guy Jean-Baptiste, Magné Nicolas
Institut de cancérologie Lucien-Neuwirth, département de radiothérapie, 108 bis, avenue Albert-Raimond, BP 60008, 42271 Saint-Priest-en-Jarez cedex, France.
Institut de cancérologie Lucien-Neuwirth, département de radiothérapie, 108 bis, avenue Albert-Raimond, BP 60008, 42271 Saint-Priest-en-Jarez cedex, France.
Bull Cancer. 2019 May;106(5):479-491. doi: 10.1016/j.bulcan.2019.02.011. Epub 2019 Apr 23.
Complementary and alternative medicines (CAMs) play more and more a significant role both in France and all over the world. Yet, their definition and their role in cancer treatments legitimately raise concerns. This article aims at establishing a picture of the CAMs admitted by the French Medical Board as well as those which are new or in common medical practices in France. We start with a brief reminder of their origin, their status and how they are used. Then, we review the literature about some of the best clinical trials using CAMs in cancer patients. To finish, we try to understand what makes CAMs so thrilling, but also why they create controversy and which common points they may have with conventional medicine.
补充和替代医学（CAMs）在法国乃至全世界都发挥着越来越重要的作用。然而，它们的定义及其在癌症治疗中的作用合理地引发了人们的关注。本文旨在梳理法国医学委员会认可的补充和替代医学，以及法国新出现的或常见的补充和替代医学。我们首先简要回顾它们的起源、地位及其使用方式。然后，我们回顾了有关在癌症患者中使用补充和替代医学的一些最佳临床试验的文献。最后，我们试图理解是什么让补充和替代医学如此令人兴奋，同时也理解它们为何引发争议，以及它们与传统医学可能存在哪些共同点。
